TARS
Tarsus Pharmaceuticals, Inc.
Price:  
48.51 
USD
Volume:  
551,535.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TARS Relative Valuation

-177.9%
Upside

As of 2025-04-22, the Relative Valuation of Tarsus Pharmaceuticals, Inc. (TARS) is (37.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.51 USD, the upside of Tarsus Pharmaceuticals, Inc. based on Relative Valuation is -177.9%.

The range of the Relative Valuation is (33.52) - (45.24) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.1x - 16.3x 14.0x
Forward P/E multiples 10.4x - 16.5x 13.2x
Fair Price (33.52) - (45.24) (37.80)
Upside -169.1% - -193.3% -177.9%
48.51 USD
Stock Price
(37.80) USD
Fair Price

TARS Relative Valuation - Historical P/E Data

Date P/E
2025-04-22 -17.65
2025-04-21 -17.46
2025-04-17 -17.72
2025-04-16 -17.77
2025-04-15 -17.67
2025-04-14 -17.53
2025-04-11 -16.71
2025-04-10 -15.88
2025-04-09 -16.51
2025-04-08 -16.06
2025-04-07 -17.09
2025-04-04 -16.92
2025-04-03 -17.83
2025-04-02 -18.53
2025-04-01 -17.60
2025-03-31 -18.48
2025-03-28 -18.62
2025-03-27 -18.23
2025-03-26 -18.36
2025-03-25 -18.47
2025-03-24 -18.84
2025-03-21 -17.98
2025-03-20 -17.96
2025-03-19 -17.83
2025-03-18 -16.61
2025-03-17 -17.09
2025-03-14 -17.30
2025-03-13 -16.72
2025-03-12 -16.95
2025-03-11 -16.97
2025-03-10 -16.04
2025-03-07 -16.72
2025-03-06 -15.68
2025-03-05 -16.03
2025-03-04 -16.01
2025-03-03 -15.37
2025-02-28 -16.01
2025-02-27 -15.67
2025-02-26 -15.31
2025-02-25 -14.86
2025-02-24 -16.39
2025-02-21 -17.21
2025-02-20 -17.53
2025-02-19 -17.83
2025-02-18 -18.30
2025-02-14 -18.07
2025-02-13 -18.79
2025-02-12 -18.83
2025-02-11 -18.43
2025-02-10 -18.62